Reaffirm the right of every human being to the enjoyment of the highest attainable standard of physical and mental health, and to enjoy the benefits of scientific progress and its application in order to advance towards universal access to quality, affordable, inclusive, equitable and timely prevention, diagnosis, treatment, care and awareness-raising related to antimicrobial resistance, and addre. [...] Underscore that environmental factors contribute to the development and spread of antimicrobial resistance and the need for priority actions to prevent and address the discharge of antimicrobials and their metabolites into the environment from a wide range of sectors and services, including sanitation and sewage, waste, wastewater, healthcare, pharmaceutical manufacturing, crop production and terr. [...] Recognize the benefits of public-private partnerships in the development of and access to antimicrobials, vaccines, diagnostics and alternatives to antimicrobials and in contributing to supply chain sustainability, and take note of the work of the Combatting Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) and the Global Antibiotic Research and Development Partnership (GARDP);. [...] Explore, encourage and promote a range of innovative incentives and financing mechanisms for multisectoral health research and development to address antimicrobial resistance, and a stronger and transparent partnership between the public and the private sectors as well as academia and the scientific community, acknowledging the important role played by the private sector in research and developmen. [...] Recognize the important role played by the private sector in research and development of innovative medicines and continue to support voluntary initiatives and incentive mechanisms that separate the cost of investment in research and development from the price and volume of sales, facilitate equitable and affordable access to new tools and other results to be gained through research and developmen.
Authors
- Pages
- 15
- Published in
- United States of America
Table of Contents
- Version under silence 30 August 2024 1
- Political Declaration of the High-level Meeting on Antimicrobial Resistance 1
- Version under silence 30 August 2024 2
- Version under silence 30 August 2024 3
- I. Governance 3
- Version under silence 30 August 2024 4
- Commitments 4
- Version under silence 30 August 2024 5
- II. Financing 5
- Commitments 5
- Version under silence 30 August 2024 6
- III. Access 6
- Commitments 6
- Version under silence 30 August 2024 7
- IV. Coordinated Multisectoral Response 7
- Version under silence 30 August 2024 8
- Commitments 8
- Version under silence 30 August 2024 9
- Commitments 9
- Version under silence 30 August 2024 10
- Commitments 10
- Version under silence 30 August 2024 11
- Commitments 11
- V. Research and Development Training Innovation and Manufacturing 11
- Version under silence 30 August 2024 12
- Commitments 12
- Version under silence 30 August 2024 13
- Version under silence 30 August 2024 14
- VI. Surveillance and Monitoring 14
- Commitments 14
- VII. Follow up 14
- Version under silence 30 August 2024 15